Embecta AID System in Adults With Type 2 Diabetes

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 31, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

May 31, 2026

Conditions
Type 2 DiabetesType 2 Diabetes Mellitus (T2DM)Type 2 DMT2DM With Inadequate Glycemic ControlT2DM (Type 2 Diabetes Mellitus)T2DT2DM
Interventions
DEVICE

An AID System.

The embecta Automated Insulin Delivery (AID) System is a closed loop system comprised of 3 components: the embecta insulin pump, a Smartphone with the Tidepool Loop app, and the Dexcom G6 CGM

OTHER

Standard of Care (SC)

Participants will continue to use their current therapy for T2D.

Trial Locations (9)

10029

Icahn School of Medicine at Mt. Sinai, New York

UT Southwestern, Dallas

11106

NYC Research, Long Island City

46202

Indiana Universtiy School of Medicine, Indianapolis

75039

Tekton Research, Irving

78681

Texas Diabetes & Endocrinology, Round Rock

84093

DETS Utah, Sandy City

94304

Stanford, Palo Alto

94598

Diablo Research, Walnut Creek

Sponsors
All Listed Sponsors
collaborator

Jaeb Center for Health Research

OTHER

lead

Embecta Corp.

INDUSTRY